Market Research Logo

Low Dosage Hydrate Inhibitors - Global Market Outlook (2015-2022)

Low Dosage Hydrate Inhibitors - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Low Dosage Hydrate Inhibitors Market is valued at $XX billion in 2015 and is projected to reach $XX billion by 2022 growing at a CAGR of XX% from 2015 to 2022. Increasing research applications and growing demand for high consumption of crude oil are some of the key factors driving the market growth. Population growth and industrialization are some of the key drivers in this market growth. Furthermore, growing population and rapid industrialization generate an increase in demand of energy. Increasing energy demand leads to higher production of oil which in turn, leads to the growth of low dosage hydrate inhibitors. However, cost effective, continuous fabrication of crude oil and low dosage hydrate inhibitor usage are the restraints hampering this market growth. North American region is expected to register a significant growth for these products over the forecast period.

Some of the key players in the market include Ashland, Halliburton and NALCO (ECOLAB COMPANY), NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Maris LLC, LEWA ,Woodview Technology and BASF.

Basis Covered:
Anti-Agglomerate (AA) inhibitors
Kinetic Hydrate Inhibitors (KHI)

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Low Dosage Hydrate Inhibitors Market, By Basis
5.1 Introduction
5.2 Anti-Agglomerate (AA) inhibitors
5.3 Kinetic Hydrate Inhibitors (KHI)
6 Global Low Dosage Hydrate Inhibitors Market, By Geography
6.1 North America
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia Pacific
6.4 Rest of the World
6.4.1 Middle East
6.4.2 Brazil
6.4.3 Argentina
6.4.4 South Africa
6.4.5 Egypt
7 Key Developments
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
8 Company Profiling
8.1 Ashland
8.2 Halliburton
8.3 NALCO (ECOLAB COMPANY)
8.4 Woodview Technology
8.5 BASF
8.6 NEFTECHIM Technologies
8.7 JSC Gazprom Neftekhim Salavat
8.8 Clariant Chemicals
8.9 GasHydrate LLC
8.10 Evonik
8.11 Ecolab
8.12 ClariantOilServices
8.13 Yara International
8.14 Stella Maris LLC
8.15 LEWA
List of Tables
Table 1 Global Low Dosage Hydrate Inhibitors Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 3 Global Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 4 Global Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 5 North America Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 6 North America Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 7 North America Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 8 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 9 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 10 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 11 Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 12 Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 13 Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 14 Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 15 Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 16 Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report